A business in context

SABS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-11-17 · 7996 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-09-30 · 0001193125-26-448600

  2. 8-K · Current report

    Report date 2026-10-13 · 0001193125-26-419769 · Items 8.01,9.01

  3. 4 · Ownership change

    Report date 2026-09-17 · 0001193125-26-395552

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-336783

  5. 8-K · Current report

    Report date 2026-07-07 · 0001193125-26-296936 · Items 7.01,9.01

  6. 4 · Ownership change

    Report date 2026-06-25 · 0001193125-26-285722

  7. 8-K · Current report

    Report date 2026-06-18 · 0001193125-26-275976 · Items 5.07

  8. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-218195

  9. 8-K · Current report

    Report date 2026-04-28 · 0001193125-26-204125 · Items 1.01,9.01

  10. DEF 14A · Proxy statement

    Report date 2026-06-18 · 0001193125-26-197607

  11. 8-K · Current report

    Report date 2026-04-22 · 0001193125-26-168569 · Items 7.01,9.01

  12. 4 · Ownership change

    Report date 2026-03-24 · 0001193125-26-124231

  13. 8-K · Current report

    Report date 2026-03-17 · 0001193125-26-114730 · Items 1.01,8.01,9.01

  14. 8-K · Current report

    Report date 2026-03-10 · 0001193125-26-099376 · Items 7.01,8.01,9.01

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001833214-26-000003

  16. 4 · Ownership change

    Report date 2026-02-03 · 0001193125-26-039577

  17. 4 · Ownership change

    Report date 2026-02-05 · 0001193125-26-039564

  18. 4 · Ownership change

    Report date 2026-02-03 · 0001193125-26-039537

  19. 4 · Ownership change

    Report date 2026-02-03 · 0001193125-26-039524

  20. 4 · Ownership change

    Report date 2026-02-03 · 0001193125-26-039508

  21. 8-K · Current report

    Report date 2026-01-12 · 0001193125-26-010515 · Items 7.01,9.01

  22. 8-K · Current report

    Report date 2026-01-05 · 0001193125-26-005487 · Items 5.02,7.01,9.01

  23. 8-K · Current report

    Report date 2025-12-29 · 0001193125-25-335267 · Items 8.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-280572

  25. 8-K · Current report

    Report date 2025-09-30 · 0001193125-25-225119 · Items 5.02,9.01

  26. 8-K · Current report

    Report date 2025-09-26 · 0001193125-25-220721 · Items 5.02,5.07,9.01

  27. DEF 14A · Proxy statement

    Report date 2025-09-26 · 0001193125-25-192856

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-104566

  29. 8-K · Current report

    Report date 2025-07-21 · 0000950170-25-097078 · Items 1.01,3.02,5.03,8.01,9.01

  30. 8-K · Current report

    Report date 2025-07-17 · 0000950170-25-096645 · Items 5.07

  31. DEF 14A · Proxy statement

    Report date 2025-07-17 · 0000950170-25-080361

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-067554

  33. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-046994

  34. 8-K · Current report

    Report date 2025-01-30 · 0000950170-25-014627 · Items 1.01,2.01,9.01

  35. 8-K · Current report

    Report date 2025-01-28 · 0000950170-25-009474 · Items 8.01,9.01

  36. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-122443

  37. 8-K · Current report

    Report date 2024-09-09 · 0000950170-24-104564 · Items 7.01,9.01

  38. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000950170-24-094084

  39. 8-K · Current report

    Report date 2024-07-26 · 0000950170-24-088247 · Items 5.02,7.01,9.01

  40. 8-K · Current report

    Report date 2024-06-27 · 0000950170-24-078622 · Items 5.07

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-11-14 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

1 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-17
2026-09-18
Kropotova AlexandraF · Tax / exercise payment
Disposed
Common Stock473.0n/a

Identity & relationships

Wikidata structured data · retrieved 2026-11-14 · 1656 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001833214SAB Biotherapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-11-14 · 1196 checked identities; 0 unavailable records

Search names and former names
  • Big Cypress Acquisition Corp. · former SEC name · 2020-12-07 to 2021-10-22

Revenue in constant purchasing power

USD revenue expressed in 2026-10 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$1.32M$1.42M
2023-12-31$2.24M$2.48M
2022-12-31$23.90M$27.56M
2021-12-31$60.88M$75.81M
2020-12-31$55.24M$72.03M

Bureau of Labor Statistics · retrieved 2026-11-17 · 9 selected series; gaps remain missing

Explore the CPI history ↗